Overview

Prospective Evaluation of Bleeding Risk of Anticoagulant and Anti-platelet Therapy

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
0
Participant gender:
All
Summary
This study will evaluate bleeding risk and differences in outcomes in patients receiving and not receiving anticoagulant or antiplatelet therapy
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Pain Management Center of Paducah
Treatments:
Anticoagulants
Platelet Aggregation Inhibitors
Criteria
Inclusion Criteria:

- Subjects undergoing interventional techniques. Subjects who were able to give
voluntary, written informed consent.

Exclusion Criteria:

- All those things, patients on heparin, dextran, and low molecular heparin